Published in CMAJ on September 01, 1992
Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. Am J Transplant (2008) 1.75
Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clin J Am Soc Nephrol (2008) 1.06
Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg (2004) 1.04
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Kidney Int (2009) 1.03
Recent developments in kidney transplantation--a critical assessment. Am J Transplant (2009) 1.02
Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation. Biologics (2009) 0.93
Renal transplantation with early steroid withdrawal. Pediatr Nephrol (2008) 0.88
Minimization of steroids in kidney transplantation. Transpl Int (2008) 0.87
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation (2000) 0.87
Four decades of glucocorticosteroid immunosuppression. CMAJ (1992) 0.80
Steroids in kidney transplant patients. Semin Immunopathol (2011) 0.80
Steroid elimination-who, when, how? Transplant Proc (2008) 0.79
Kidney transplant half-life (t[1/2]) after rapid discontinuation of prednisone. Transplantation (2009) 0.78
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients. Transplant Res (2013) 0.78
Steroid- and calcineurin inhibitor free immunosuppression in kidney transplantation: state of the art and future developments. World J Urol (2007) 0.76
Effect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study. NDT Plus (2010) 0.76
Impact of steroid maintenance on the outcomes in first-time deceased donor kidney transplant recipients: Analysis by induction type. World J Transplant (2014) 0.75
Early corticosteroid withdrawal regimen in a living donor kidney transplantation program. Indian J Nephrol (2014) 0.75
Steroid withdrawal after renal transplantation: a retrospective cohort study. BMC Med (2017) 0.75
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Cyclosporine. N Engl J Med (1989) 5.67
Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J Exp Med (1990) 3.45
Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunology (1976) 2.76
A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay (1981) 2.55
Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol (1990) 2.37
Effects of cyclosporine A on T cell development and clonal deletion. Science (1988) 2.08
Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation (1985) 1.83
Advantages of low dose steroid from the day after renal transplantation. Transplantation (1980) 1.22
Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet (1989) 1.11
Regulation of T lymphocyte apoptosis. Signals for the antagonism between activation- and glucocorticoid-induced death. J Immunol (1991) 1.06
Low dose oral prednisolone in renal transplantation. Lancet (1982) 1.05
Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death. J Immunol (1992) 1.01
Inaccuracy of estimated creatinine clearance for prediction of iothalamate glomerular filtration rate. Am J Kidney Dis (1984) 0.98
Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation (1987) 0.94
The influence of the pattern of inflammation and administration of steroids on class II MHC antigen expression in renal transplants. Transplantation (1986) 0.94
A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients. Transplantation (1990) 0.93
Glucocorticosteroids and organ transplantation. Transplantation (1984) 0.91
Causes of graft loss beyond two years in the cyclosporine era. Transplantation (1990) 0.88
Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation (1989) 0.87
Prevention of syngeneic graft-versus-host disease by recovery of thymic microenvironment after cyclosporine. Transplantation (1991) 0.84
Cyclosporine mono-drug therapy. Transplant Proc (1988) 0.81
A controlled trial of steroids in cyclosporine-treated renal transplant recipients. Transplantation (1987) 0.80
Impact of race on the outcome of renal transplantation under cyclosporine-prednisone. Transplant Proc (1989) 0.80
Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone. Transplantation (1990) 0.79
Low-dose cyclosporine, anti-lymphocyte globulin, and steroids in first cadaveric renal transplantation. Transplant Proc (1988) 0.78
Withdrawal of methylprednisolone at the sixth month in renal transplant recipients treated with cyclosporine. Transplant Proc (1987) 0.78
Should cyclosporine be continued indefinitely? Transplant Proc (1991) 0.78
A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group. Transplant Proc (1987) 0.78
Effects of cyclosporine, azathioprine, and steroids on the renal transplant, on the cytologic patterns of intragraft inflammation, and on concomitant rejection-associated changes in recipient blood. Transplant Proc (1988) 0.78
Rejection reaction after stopping prednisolone in kidney-transplant recipients taking cyclosporine. N Engl J Med (1986) 0.77
Pharmacokinetics of cyclosporine in solid organ transplantation. Transplant Proc (1986) 0.77
Cadaver renal transplantation without maintenance steroids. Transplant Proc (1989) 0.77
Cyclosporine alone or in combination with prednisone in cadaveric renal transplantation. Transplant Proc (1984) 0.77